The release of carboxypeptidase H activity from isolated rat islets was determined and compared to the secretion of immunoreactive insulin. Analysis of pancreatic islet cells sorted into , and non-fl types indicated that approx. 800 of islet carboxypeptidase H activity is present in the fl cell. The release of both insulin and carboxypeptidase H was stimulated markedly by increasing the glucose concentration in the medium from 2.8 to 28 mm. The fractional release was in accordance with the observed cellular distribution of both proteins. The secretory response was biphasic with time, with an initial rapid transient phase of release within 5 min, followed by a more sustained response. The concentration-dependencies of glucose stimulation of release of insulin and carboxypeptidase H were similar, with a threshold for stimulation around 5.6 mMglucose and maximal stimulatory response at 16.7-28 mM-glucose. The release of both proteins was inhibited by 20 mM-mannoheptulose, removal of Ca2" from the medium and addition of I /LM-noradrenaline. The combination of 10 mM-4-methyl-2-oxopentanoate and 10 mM-glutamine stimulated the release of carboxypeptidase H and insulin, as did 3-isobutyl-1 -methylxanthine and 350 /LM-tolbutamide in the presence of glucose. It is evident that carboxypeptidase H is released from the pancreatic fl-cell by an exocytotic process from the same intracellular compartment as insulin. The release of carboxypeptidase H by a constitutive process was at best equivalent to 0.4 %/h, or less than 20% of the maximal rate of release via the regulated pathway. It is concluded that carboxypeptidase H can be used as a sensitive index of fl-cell secretion and an alternative marker to the insulin-related peptides.
INTRODUCTION
Carboxypeptidase H (EC 3.4.17.10 ) is a cobaltstimulated carboxypeptidase B-like enzyme which removes C-terminal basic amino acids from the peptide substrates produced by endoproteolytic cleavage of precursor proteins. It is broadly distributed in tissues secreting polypeptide hormones and neurotransmitters, where it is concentrated in secretory granules along with the major secreted products (Fricker & Snyder, 1982 Docherty & Hutton, 1983) . In the pancreatic f-cell it constitutes approx. 2-5°/ of the total granule protein (Hutton, 1984) , and is present mostly as a soluble granule matrix constituent . Subcellular-fractionation studies indicate that the enzyme may serve as a useful marker for the insulin secretory granule compartment (Docherty & Hutton, 1983; , and it is thus potentially an alternative to measurement of insulin and C-peptide as a means of determining the secretory response of the cell.
The principal objective of the present studies was to document the secretion of carboxypeptidase H from isolated rat islets in comparison with that of insulin, and to evaluate the data within the context of the exocytotic model of insulin secretion as proposed originally by Palade (1975) . A number of additional factors, however, need to be considered. The fl-cell is not the only glucosesensitive cell of the islet likely to contain carboxypeptidase H activity. Also, the enzyme is not necessarily concentrated to the same extent as insulin within the secretory-granule compartment, especially as it may play a role in the processing of other precursor proteins, which are either secreted constitutively or segregated to other cellular locations. Finally, the biosynthesis of the enzyme is not responsive to insulinotropic stimuli (Guest et al., 1989) , and its intragranular concentration could thus vary relative to that of insulin, depending on the physiological status of the cell. This could also be manifest as differences in the relative composition of insulin and carboxypeptidase H between separate pools of granules within the same cell or between cells which exhibit different thresholds for the activation of insulin secretion or biosynthesis (Pipeleers, 1987) .
EXPERIMENTAL Materials
Analytical-grade biochemicals were obtained from Sigma Chemical Co. or BDH Chemicals (both of Poole, Dorset, U.K.), unless specified otherwise. Guanidinomercaptosuccinic acid was obtained from Cambridge Biosciences (Cambridge, U.K.), [2,5-2H(n)]benzoyl-PheAla-Arg (30 Ci/mmol) from New England Nuclear (Stevenage, Herts., U.K.) and benzoyl-Phe-Ala-Arg from Neosystems Laboratories (Strasbourg, France).
Preparation of islets
Pancreatic islets of Langerhans were isolated from 7-12-week-old New England Deaconess Hospital rats by § To whom correspondence should be addressed.
Vol. 264 collagenase digestion, as described previously (Guest et al., 1989) , and collected into an incubation medium consisting ofmodified Krebs bicarbonate buffer (120 mMNaCl, 5 mM-KCl, I mM-MgSO4, 2.5 mM-CaCl2, 24 mmNaHCO3), containing 20 mM-Hepes (pH 7.4), 0.1 % bovine serum albumin and 2.8 mM-glucose.
Static incubations
Batches of 10 islets were incubated in 500,ul of incubation media, with the indicated modifications, for 90 min at 37°C under 02/CO2 (19: 1) in 1.8 ml-capacity sealed cryotubes (Nunc Cryotubes, Gibco, Paisley, Scotland, U.K.). Islets were then recovered by centrifugation for 1O s at 800 g (MSE bench-top centrifuge) and the media retained. The islets were sonicated for 10 s at 25 W (MSE Sonifer) in 500 #1 of a lysis buffer consisting of 0.025 M-Tris/HCl (pH 8.0), 2 % (w/v) albumin and 1 % Triton X-100. The lysates were centrifuged for 3 min at 13000 g (MSE Microcentaur microcentrifuge) and the supernatants retained.
Perifusion
The perifusion chamber was a I ml syringe (Monoject, Crawley, W. Sussex, U.K.) containing a 20 ,1 bed of BioGel P-2 resin (Bio-Rad Laboratories, Hemel Hempstead, Herts., U.K.), overlying a layer of packed glass wool (2-5 mm) in the tip. Groups of 200 islets in incubation media were transferred on to the gel, and the chamber was made to a volume of 30 ,1 by insertion of the rubber tip of the syringe plunger. The chamber was connected to the medium reservoirs through a syringe needle (Monoject; 0.5 mm x 16 mm), attached to 0.41 mminternal-diam. tubing (Technicon, New York, NY, U.S.A.), inserted through the plunger tip. The islets were perifused at a flow rate of 2 ml/min (P1 peristaltic pump; Pharmacia, Stockholm, Sweden), with incubation media containing either 2.8 mm or 28.0 mM-glucose at 37°C under 02/CO2 (19: 1). The perfusate was collected (Frac-100 fraction collector; Pharmacia) in 1 ml fractions into 1.5 ml-capacity micro-centrifuge tubes (Alpha, Eastleigh, Hants., U.K.). The islets were finally recovered from the chamber and lysed as described above.
Preparation of soluble and membrane fractions
Islets were first sonicated for 15 s at 25 W in 500 ,ul of 10 mM-Tris/HCl (pH 8.0), containing 1 M-NaCl. The lysates were centrifuged for 5 min at 13000 g (MSE Microcentaur) and the supernatants (soluble activity) were retained. The pellets were sonicated as described above in the same buffer containing 1 % Triton X-100, centrifuged, and the supernatants (membrane-bound activity) retained.
Preparation of islet cells
Single , and non-f islet cells were prepared as described previously (Van De Winkel et al., 1982; Pipeleers et al., 1985) by autofluorescence-activated cell sorting, which distinguishes f-cells from the smaller non-f-cells by their greater light-scatter activity and FAD autofluorescence. f-cell and non-fl-cell purity was assessed by immunostaining for the hormones insulin, glucagon, somatostatin and pancreatic polypeptide (Pipeleers et al., 1985) , and cross-contamination was typically less than 500. The DNA content of islet cells was measured by the method of Downs & Wilfinger (1983) .
Assay procedures
Carboxypeptidase H activity was determined by. a modification of the radiometric method of Rossier et al. (1989) . Briefly, islet lysates and media were made to 25 ,l with lysis buffer in 1.5 ml-capacity micro-centrifuge tubes (Alpha) and preincubated at 37°C for 10 min with 25 #1 of 0.1 M-sodium acetate (pH 5.6) containing 2 %/ albumin, 4 mM-CoCl, and with or without 50/Mguanidinomercaptosuccinic acid. The reactions were initiated with 50 tl of 0.1 M-sodium acetate (pH 5.6) containing 0.2 mm unlabelled substrate benzoylPhe-Ala-Arg and 16 nM 3H-labelled substrate (approx. 30000 c.p.m.). Reactions were terminated with 680 jul of 0.25 M-HCI/CH3CN (10:7, v/v). The tubes were transferred into 20 ml screw-capped scintillation vials, and 4 ml of toluene containing 0.5% 2,5-diphenyloxazole and 0.02% 1 ,4-bis-(5-phenyloxazol-2-yl)benzene was added. The vials were shaken by hand for 1O s, left overnight at 4°C and subjected to liquid-scintillation counting. Under these conditions the product, [3H]-benzoyl-Phe-Ala, is partitioned quantitatively into the scintillant and its radioactivity is thus registered, whereas the uncleaved substrate remains in the aqueous phase. The difference between the radioactivity registered in the presence and absence of guanidinomercaptosuccinic acid was taken to represent carboxypeptidase H activity.
Insulin immunoreactivity was assayed by a two-site immunoradiometric technique as described by Sobey et al. (1989) , by using rat insulin as standard and an immunoadsorbent prepared from guinea-pig polyclonal antisera raised against bovine insulin. Lactate dehydrogenase was determined by the method ofNielands (1955), modified as described by Lowry & Passonneau (1972) 
RESULTS

Enzymic properties
Carboxypeptidase H activity in freshly isolated rat islets, determined in the presence of 1 mM-CoCI2 was 238.6 + 21.8 pmol/min per islet (6). Other activities capable of hydrolysing the same substrate, benzoyl-PheAla-Arg, in the presence of the active-site-directed inhibitor guanidinomercaptosuccinic acid accounted for less than 1.50% of the carboxypeptidase H activity. The extent of cobalt activation (4-5-fold) and the pH optimum (5.5) of the islet activity were indistinguishable from those of the enzyme purified from transplantable rat insulinoma 3-fold between experiments, thus suggesting that a component of their release might be related to non-specific damage to islets during the isolation procedure. The release of lactate dehydrogenase, a cytosolic marker, in a separate series of experiments ranged from 0.3 to 1 % of the cellular content, further supporting this idea.
The release of carboxypeptidase H activity was markedly stimulated by incubation of islets for 90 min in the presence of 16.7-28 mM-glucose. This was significantly lower than the corresponding insulin release when expressed as a percentage of the total islet content [6.95+0.71% (24) versus 9.41 + 0.88% (24) respectively (P < 0.05)], but did not differ when carboxypeptidase H release was expressed in terms of total f-cell content [8.48+0.87% (24)].
Both insulin and carboxypeptidase H were released from islets with a sigmoidal dependence on the concentration of glucose in the incubation medium (Fig. 1) . The release of both proteins showed a threshold for stimulation above 5.6 mM-glucose, with half-maximal response at approx. 10 mM-glucose and maximal stimulation at 16.7-28.0 mM-glucose. Linear-regression analysis showed a close correlation (r2 = 0.987) between insulin and carboxypeptidase H release at stimulatory glucose concentrations. The slope of the regression (0.62) approaches the estimated ratio of soluble carboxypeptidase H in the f-cell to the total islet content (0.75; see above). Over the range of glucose concentrations which induced release, there was no indication of a divergence from a linear relationship. This suggested that both the secretory granules and cells from which release was occurring had the same relative contents of insulin and carboxypeptidase H.
Modifiers of release
The release of carboxypeptidase H activity and immunoreactive insulin induced by 16.7 mM-glucose was markedly decreased in Ca2`-depleted media containing 1 mm-EGTA (Table 2) . Mannoheptulose (20 mM), which has been shown to inhibit glucose metabolism in islets (Ashcroft & Randle, 1970) , and noradrenaline (1 /tM) also reversed significantly the stimulatory effect of glucose on the release of both proteins. Tolbutamide (350 /ZM) in the presence of 5.6 mM-glucose and the combination of 10 mM-4-methyl-2-oxopentanoate and 10 mM-glutamine were potent stimuli for the release of both proteins (Table   3 ). There was a close correlation between release of carboxypeptidase H and insulin under all these conditions. Linear-regression analysis of the data in Tables 1 and 2 , excluding the incubations performed in the presence of the phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine (I /aM), indicated that the release of Vol. 264 Table 2 . Effect of inhibitors on release of insulin and carboxypepti4ase H Islets were incubated for 90 min as indicated, and the release of insulin and carboxypeptidase H was determined by radioimmunoassay and enzymic assay respectively (see the text for further details). All results are means + S.E.M. of at least six independent observations, and are expressed as percentage released of the islet content at the end of the experiment (insulin 13.1 + 1.2 pmol/islet, carboxypeptidase H 241.9 ± 7.9 pmol/min per islet). Levels of significance for difference between value and control value (16.7 mM-glucose): * P < 0.00 1.
Release (0) Table 3 . Effect of secretagogues on release of insulin and carboxypeptidase H Islets were incubated for 90 min as indicated, and the release of insulin and carboxypeptidase H was determined by radioimmunoassay and enzymic assay respectively (see the text for further details). All results are means + S.E.M. of at least six independent observations, and are expressed as percentage released of the islet content at the end of the experiment (insulin 10.0 + 0.9 pmol/islet, carboxypeptidase H 179.4 + 25.5 pmol/min per islet). Abbreviations: IBMX, 3-isobutyl-l-methylxanthine; KIC, 4-methyl-2-oxopentanoate ('ketoisocaproate').
Release (0 Proportionately more carboxypeptidase H release occurred in the presence of 3-isobutyl-1-methylxanthine (Table 3 ). The possibility that non-f islet cells contributed to its release in this case warrants investigation.
Dynamics of release
The release ofcarboxypeptidase H from perifused islets was stimulated markedly by increasing the glucose concentration in the medium from 2.8 to 28 mm (Fig. 2) . This increase in release followed a pattern similar to the biphasic pattern characteristic of insulin release (Curry et al., 1968) . In both cases stimulation occurred after a delay of 90 s, reached an initial peak at 3 min, followed by a nadir at 5 min and a more sustained response over the subsequent 10 min. Linear-regression analysis again showed a close correlation between the release of both proteins (r2 = 0.899) and a slope (0.63) which approximated to the estimated content of soluble carboxypeptidase H in the fl-cell relative to the total islet content. It was apparent that the release of carboxypeptidase H was not limited by its diffusion from the interstitial space within the islet, even though the protein has a molecular size almost 10-fold that of insulin. Since carboxypeptidase H was released in the same proportion to insulin during the first phase of secretion as in longerterm static incubations, it is evident that the secretorygranule pools and cells involved in the first and second phases of release have the same average relative compositions of the two proteins.
DISCUSSION
Carboxypeptidase H is widely distributed in the secretory granules of endocrine and neural tissues, where it is involved in the proteolytic processing of polypeptide hormones and neuropeptides (Fricker & Snyder, 1982 . High levels of the enzyme are present in the pituitary and pancreatic islets, with substantially lower levels in the adrenal medulla and various brain regions. There is little evidence for an extracellular function of the enzyme, since it is optimally active at the acidic pH of the secretory granule and retains very little activity at the neutral pH of plasma (Fricker & Snyder, 1982; Docherty & Hutton, 1983) .
Carboxypeptidase H has been shown previously to be release of carboxypeptidase H and the hormones in question from these tissues has often not been a precise one, with considerable variation in the relative compositions of secreted and cellular material. Nonparallel release of secretory-granule constituents has also been reported in other tissues (see Burgess & Kelly, 1987) , and in some cases was construed as evidence against the exocytotic model of secretion (Rothman, 1975) . The present studies with isolated rat islets, however, show that the releases of carboxypeptidase H and insulin were almost exactly parallel under a wide range of conditions. It was evident that the fl-cell is a major cellular source of carboxypeptidase H in islets. Along with previous morphological data (Kakiuchi & Sobue, 1983) and studies on the co-secretion of insulin and Cpeptide (Rubenstein et al., 1969; Melani et al., 1970) , these data provide strong experimental support for the concept that secretion from the pancreatic f-cell occurs by exocytosis of secretory granules, which results in the quantal release of the soluble contents of the granule.
Whether carboxypeptidase H release from the fl-cell occurs exclusively by a regulated process remains an open question, since the basal release of the enzyme consistently exceeded that of insulin both under nonstimulatory conditions and when release by the regulated pathway was inhibited. One possible explanation for this difference is that it constitutes basal or stimulated release from non-, islet cells, the majority of which contain the enzyme (P. C. Guest, L. Orci & J. C. Hutton, unpublished work) . It is also conceivable that release of carboxypeptidase H occurred by a constitutive process from the fl-cell. However, it was not experimentally feasible to test this possibility, since the basal rates of release were of the same order as the extent of cellular lysis, as measured by the release of a cytosolic marker protein. As a consequence, only an upper estimate of the rate of constitutive release could be derived. This was equivalent to 0.4 0% of the cellular contents/h, or around 20% of the maximal rate of secretion via the regulated pathway (as represented by release in the presence of 16.7 mM-glucose plus 3-isobutyl-1 -methylxanthine).
These studies demonstrate that carboxypeptidase H secretion from isolated rat islets occurs in reponse to the same intracellular signals effecting the secretion of insulin. We conclude that its measurement provides an alternative and independent method of determining the rates of exocytosis from the pancreatic f-cell in vitro. Assays for this enzyme should find general application in experimental situations in which immunoassay of insulin is not feasible, for example where the secreted product is structurally altered or in studies where the effects of immunologically cross-reactive peptides on insulin secretion are of interest.
